The 76ers are riding a three-game winning streak, with all of the victories on the road. The team is healthy and finding more ...

As Colorado aims to hit ambitious climate action goals, local communities, including those along the Western Slope, are ...

Enhertu plus Perjeta is the first new first-line treatment for HER2-positive breast cancer in over a decade, approved by the FDA. Enhertu, a HER2-directed antibody-drug conjugate, inhibits tumor ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

This content was first published in Golf Journal, a quarterly print and monthly digital publication exclusively for USGA Members. To be among the first to receive Golf Journal and to learn how you can ...

It can look different and feel different, but it is only different if, in fact, it actually is different. Soon enough, all the good, positive vibes mustered by the Giants about their offensive line ...

MINNEAPOLIS — When starting left tackle Cam Robinson went down with a leg injury on the first day of training camp practices at the Greenbrier last week, there was major concern about how the ...

The Tennessee Titans offensive line is a work in progress going into the season, but there is reason to believe that they will be better in the upcoming campaign. While starting center Lloyd ...

ENT-03 is a novel, centrally acting aminosterol with Protein Tyrosine Phosphatase 1B (PTP1B) inhibitory activity, which normalizes glucose, improves insulin sensitivity, and causes weight loss by ...

In the DESTINY-Breast09 trial, presented at this year's American Society of Clinical Oncology (ASCO) annual meeting, first-line trastuzumab deruxtecan (T-DXd; Enhertu) combined with pertuzumab ...

“Keep your face towards the sunshine and shadows will fall behind you.” — Walt Whitman “‎Life is a shipwreck, but we must not forget to sing in the lifeboats.” ― Voltaire “Life does not have to be ...